Defining patient value in haemophilia care
Open Access
- 1 July 2018
- journal article
- editorial
- Published by Wiley in Haemophilia
- Vol. 24 (4) , 516-518
Abstract
No abstract availableFunding Information
- Pfizer
- Bayer
- Baxter International
- CSL Behring
This publication has 18 references indexed in Scilit:
- The cost of severe haemophilia in Europe: the CHESS studyOrphanet Journal of Rare Diseases, 2017
- Outcome measures for adult and pediatric hemophilia patients with inhibitorsEuropean Journal of Haematology, 2017
- Health‐related quality of life questionnaires in individuals with haemophilia: a systematic review of their measurement propertiesHaemophilia, 2017
- Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspectiveHaemophilia, 2016
- Defining an International Standard Set of Outcome Measures for Patients With Hip or Knee Osteoarthritis: Consensus of the International Consortium for Health Outcomes Measurement Hip and Knee Osteoarthritis Working GroupArthritis Care & Research, 2016
- Rationale for individualizing haemophilia careBlood Coagulation & Fibrinolysis, 2015
- Development of a Standardized Set of Patient-centered Outcomes for Advanced Prostate Cancer: An International Effort for a Unified ApproachEuropean Urology, 2015
- A proposed set of metrics for standardized outcome reporting in the management of low back painActa Orthopaedica, 2015
- What Is Value in Health Care?New England Journal of Medicine, 2010
- Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth and Quality of Life Outcomes, 2006